We studied the effect of diindolylmethane in a dose of 600 mg/kg on the change in adhesion strength of alveolocytes and hepatocytes in CBA mice. Diindolylmethane was administered intragastrically to experimental animals for 10 days, controls intragastrically received an equivalent volume of saline. At the end of the therapeutic period, mice treated with diindolylmethane showed a significant increase in the adhesion strength of alveolocytes by 16% (p=0.003) and hepatocytes by 61% (p=0.0001) in comparison with the control group, which indicates the antipromotor activity of diindolylmethane.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Krakhmal NV, Zavyalova MV, Vtorushin SV, Perelmuter VM, Denisov EV. Cancer invasion: Patterns and mechanisms. Acta Naturae. 2015;7(2):17-28.
Kuznetsov IN, Ashrafyan LA, Kiselev VI, Drukh VM, Muyzhnek EL, Pchelintseva OI. Preclinical study of effects of a novel 3,3’-diindolylmethane based pharmaceutical composition on reproductive function and immune system. Vestn. Ross. Nauch. Tsentra Rentgenradiologii Minzdrava Rossii. 2013;(13-3):14. Russian.
Malenkov AG, Modyanova EA. Biological Basis of Prevention and Non-Toxic Therapy of Cancer. Moscow, 2006. Russian.
Modyanova EA, Bocharova OA, Ushakov VF. Mechanical properties of intercellular junctions of hepatocytes in inbred mice and predisposition to spontaneous hepatoma. Bull. Exp. Biol. Med. 1980;89(4):492-495.
Banerjee S, Kong D, Wang Z, Bao B, Hillman GG, Sarkar FH. Attenuation of multi-targeted proliferation-linked signaling by 3,3′-diindolylmethane (DIM): from bench to clinic. Mutat. Res. 2011;728(1-2):47-66.
Banerjee S, Parasramka MA, Sarkar FH. Cellular, molecular and biological insight into chemopreventive and therapeutic potential of 3,3’-diindolylmethane (DIM). Nutraceuticals and Cancer. Sarkar FH, ed. New York, 2012. P. 111-133.
Chen I, Safe S, Bjeldanes L. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem. Pharmacol. 1996;51(8):1069-1076.
Li F, Chen C, Chen SM, Xiao BK, Tao ZZ. ERK signaling mediates long-term low concentration 3,3’-diindolylmethane inhibited nasopharyngeal carcinoma growth and metastasis: an in vitro and in vivo study. Oncol. Rep. 2016;35(2):955-961.
Li WX, Chen LP, Sun MY, Li JT, Liu HZ, Zhu W. 3’3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling. Oncotarget. 2015;6(27):23,776-23,792.
Sepkovic DW, Stein J, Carlisle AD, Ksieski HB, Auborn K, Bradlow HL. Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model. Cancer Epidemiol. Biomarkers Prev. 2009;18(11):2957-2964.
Staub RE, Onisko B, Bjeldanes LF. Fate of 3,3’-diindolylmethane in cultured MCF-7 human breast cancer cells. Chem. Res. Toxicol. 2006;19(3):436-442
Tilton SC, Hendricks JD, Orner GA, Pereira CB, Bailey GS, Williams DE. Gene expression analysis during tumor enhancement by the dietary phytochemical, 3,3’-diindolylmethane, in rainbow trout. Carcinogenesis. 2007;28(7):1589-1598.
Weng JR, Tsai CH, Kulp SK, Chen CS. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett. 2008;262(2):153-163.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 168, No. 7, pp. 53-55, July, 2019
Rights and permissions
About this article
Cite this article
Kiselev, V.I., Sukhikh, G.T., Pchelintseva, O.I. et al. An Experimental Study of the Effect of Diindolylmethane on Alveolocyte and Hepatocyte Adhesion Strength in Mice. Bull Exp Biol Med 168, 45–47 (2019). https://doi.org/10.1007/s10517-019-04642-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-019-04642-6